Skip to content
10-Q

Quarterly Report

NEOS THERAPEUTICS, INC.

0001558370-20-013365

← back to feed
Filed
Nov 9, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 2, 2020 49.76M sh
Capex Q3 2020 · Sep 30, 2020 $241K
Capex Q3 2020 · Sep 30, 2019 $748K
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$7.64M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$12.02M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $12.74M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $16.83M
Stockholders Equity Q3 2020 · Sep 30, 2020 −$20.55M
Stockholders Equity Q3 2020 · Dec 31, 2019 −$6.13M
Stockholders Equity Q3 2020 · Sep 30, 2019 −$3.03M
Current Liabilities Q3 2020 · Sep 30, 2020 $67.16M
Current Liabilities Q3 2020 · Dec 31, 2019 $63.36M
Current Assets Q3 2020 · Sep 30, 2020 $44.01M
Current Assets Q3 2020 · Dec 31, 2019 $66.56M
Total Assets Q3 2020 · Sep 30, 2020 $64.58M
Total Assets Q3 2020 · Dec 31, 2019 $90.87M
Sga Expense Q3 2020 · Sep 30, 2020 $4.18M
Sga Expense Q3 2020 · Sep 30, 2020 $12.14M
Sga Expense Q3 2020 · Sep 30, 2019 $2.85M
Sga Expense Q3 2020 · Sep 30, 2019 $10.36M
Rd Expense Q3 2020 · Sep 30, 2020 $1.31M
Rd Expense Q3 2020 · Sep 30, 2020 $4.67M
Rd Expense Q3 2020 · Sep 30, 2019 $1.55M
Rd Expense Q3 2020 · Sep 30, 2019 $6.76M
Net Income Q3 2020 · Sep 30, 2020 −$4.91M
Net Income Q3 2020 · Sep 30, 2020 −$18.37M
Net Income Q3 2020 · Dec 31, 2019 −$16.9M
Net Income Q3 2020 · Sep 30, 2019 −$2.05M
Net Income Q3 2020 · Sep 30, 2019 −$13.41M
Net Income Q3 2020 · Dec 31, 2018 −$51.7M
Operating Income Q3 2020 · Sep 30, 2020 −$2.92M
Operating Income Q3 2020 · Sep 30, 2020 −$11.68M
Operating Income Q3 2020 · Sep 30, 2019 −$433K
Operating Income Q3 2020 · Sep 30, 2019 −$8.7M
Gross Profit Q3 2020 · Sep 30, 2020 $7.42M
Gross Profit Q3 2020 · Sep 30, 2020 $22.77M
Gross Profit Q3 2020 · Sep 30, 2019 $11.09M
Gross Profit Q3 2020 · Sep 30, 2019 $29.88M
Cost Of Revenue Q3 2020 · Sep 30, 2020 $5.12M
Cost Of Revenue Q3 2020 · Sep 30, 2020 $17.39M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $6.45M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $17.94M
Revenue Q3 2020 · Sep 30, 2020 $12.54M
Revenue Q3 2020 · Sep 30, 2020 $40.16M
Revenue Q3 2020 · Sep 30, 2019 $17.54M
Revenue Q3 2020 · Sep 30, 2019 $47.82M